Xiao-Feng
Xia
a,
Xian-Rong
Song
a,
Ning
Wang
a,
Hai-Long
Wei
b,
Xue-Yuan
Liu
a and
Yong-Min
Liang
*a
aState Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, 730000, China. E-mail: liangym@lzu.edu.cn; Fax: (+86) 931-8912582
bState Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, P. R. China.
First published on 16th November 2011
An efficient construction of multifunctionalized ring-fused tetrahydroquinolines viaplatinum-catalyzed C–H functionalization is presented. A sequence involving 1,3-OAc migration, [1,5]-hydride shift and then cyclization takes place to produce ring-fused tetrahydroquinolines. The reaction mechanism has been confirmed by a deuterium-labeling experiment.
Scheme 1 Hydrofunctionalization of allene. |
Our group is persistently interested in C–H functionalization at the α-position of tertiary amines to prepare various functionalized heterocyclic compounds.6 In conjunction with our recent investigations in the field of platinum-catalyzed hydride transfers, we were intrigued by the possibility of developing a new hydrofunctionalization of the in situ formed allenes. In contrast with a traditional hydrofunctionalization,4 such a process would first involve the transfer of a hydride onto the C(1)-carbon of the allene intermediate 2 activated by platinum formed viaplatinum-catalyzed 1,3-OAc migration of the propargylic ester 1,7 which is rarely reported (Scheme 2). The resulting vinyl-platinum species would then attack the iminium ion in a final electrophilic demetalation step to furnish the ring-fused tetrahydroquinoline compound which is the key structural element in many natural products, particularly alkaloids.8 We report herein a successful realization of this concept and the details of our discovery.
Scheme 2 Proposed Lewis acid-catalyzed process. |
Scheme 3 Plausible mechanism leading to the formation of 2o. |
Entry | Catalyst (mol%) | Additive | Solvent | T/°C | Yield (%)b |
---|---|---|---|---|---|
a Unless otherwise noted, all reactions were performed with 0.2 mmol of 1a in toluene (2.0 mL). b Isolated yields over two steps. | |||||
1 | PtCl2(10) | — | Toluene | 80 | 22 |
2 | PtCl2(15) | — | Toluene | 80 | 30 |
3 | PtCl2(10) | — | Toluene | 110 | 35 |
4 | PtCl2(15) | — | Toluene | 110 | 38 |
5 | PtCl2(15)/O2(1 atm) | — | Toluene | 110 | 46 |
6 | PtCl2(15)/Ar(1 atm) | — | Toluene | 110 | 56 |
7 | PtCl2(15)/CO(1atm) | — | Toluene | 110 | 40 |
8 | PtCl2(15)/Ar(1 atm) | LiCl (2 equiv) | Toluene | 110 | 65 |
9 | PtCl2(15)/Ar(1 atm) | LiCl (4 equiv) | Toluene | 110 | 57 |
10 | PtCl2(15)/Ar(1 atm) | LiCl (2 equiv)/4 Å MS (50 mg) | Toluene | 110 | 68 |
11 | PtCl2(15)/Ar(1 atm) | LiCl (2 equiv)/CaO (2 equiv) | Toluene | 110 | 70 |
12 | PtCl2(15)/Ar(1 atm) | LiCl (2 equiv)/ CaO (4 equiv) | Toluene | 110 | 78 |
13 | PtCl2(15)/Ar(1 atm) | LiCl (2 equiv)/CaO (6 equiv) | Toluene | 110 | 72 |
Various substrates were prepared to test the generality of this tandem sequence under the optimal conditions (Table 1, entry 12), and the results are summarized in Table 2. We extended the scope of this transformation to a wide range of electronically and structurally diverse propargylic esters. The 1,5-hydride shift proceeded smoothly for all of the tested propargylic esters to give the ring-fused tetrahydroquinolines in moderate to good yields with moderate dr values. Firstly, we screened the effect of migratory groupR4. To our delight, the acetate 1a, as an excellent substrate, afforded the highest yield, while benzoate 1b behaved better than 1c. The presence of an electron-withdrawing or -donating group in R3 was well tolerated. An electron-withdrawing substituent in R3 favored products formation (entries 7–10), while an electron-donating group slightly hindered the reaction (entries 4–6). This might be due to the fact that the electron-withdrawing substituent in R3 increases the cationic character of C1 in the allene intermediate (Scheme 2). To our delight, propargylic ester 1j was found to be equally a good candidate for the process and 78% of 2g was obtained with excellent dr value (>20:1). Substrate 1k bearing an electron-withdrawing bromine atom on the benzene ring (R1 = Br) gave the desired product 2h in 61% yield (entry 11). When both R1 and R3 were electron-withdrawing groups, a better result was achieved (entry 13). When R2 was methyl, the reactions also proceeded smoothly to give the corresponding products 2l and 2m in 60% and 50% yields, respectively. When propargylic ester 1r was subjected to the optimized conditions, the thienyl substituent in R3 was also tolerated and the product 2n was isolated in 63% yield. Unfortunately, sterically demanding ortho substituents could not participate in this reaction and acyclic tertiary aniline also failed to undergo this transformation (entry 19).
Entry | 1 | Substrates | Products | Time (h) | Yieldb (%)/d.r.c |
---|---|---|---|---|---|
a Unless otherwise noted, all reactions were performed with 0.2 mmol of propargylic esters in toluene (2.0 mL) at 110 °C. b Isolated yield after two steps. c Diastereomeric ratio is determined by 1H NMR spectroscopic analysis. d The yield is below 5%. | |||||
1 | 1a | R 1 = H, R2 = H, R3 = C6H5, R4 = Ac | 2a | 36 | 78 (2:1) |
2 | 1b | R 1 = H, R2 = H, R3 = C6H5, R4 = PhCO | 2a | 36 | 72 (6:1) |
3 | 1c | R 1 = H, R2 = H, R3 = C6H5, R4 = CH3CH2CO | 2a | 37 | 46 (4:1) |
4 | 1d | R 1 = H, R2 = H, R3 = p-MeC6H4, R4 = Ac | 2b | 35 | 50 (6:1) |
5 | 1e | R 1 = H, R2 = H, R3 = m-MeC6H4, R4 = Ac | 2c | 36 | 57 (13:1) |
6 | 1f | R 1 = H, R2 = H, R3 = 3,4-DiMeC6H3, R4 = Ac | 2d | 37 | 40 (1:1) |
7 | 1g | R 1 = H, R2 = H, R3 = p-ClC6H4, R4 = Ac | 2e | 38 | 63 (5:1) |
8 | 1h | R 1 = H, R2 = H, R3 = p-BrC6H4, R4 = Ac | 2f | 38 | 64 (8:1) |
9 | 1i | R 1 = H, R2 = H, R3 = p-BrC6H4, R4 = PhCO | 2f | 35 | 56 (5:1) |
10 | 1j | R 1 = H, R2 = H, R3 = p-CH3COC6H4 , R4 = Ac | 2g | 36 | 78 (>20:1) |
11 | 1k | R 1 = 5-Br, R2 = H, R3 = C6H5, R4 = Ac | 2h | 35 | 61 (6:1) |
12 | 1l | R 1 = 5-Br, R2 = H, R3 = C6H5, R4 = PhCO | 2h | 35 | 44 (4:1) |
13 | 1m | R 1 = 5-Br, R2 = H, R3 = p-BrC6H4, R4 = Ac | 2i | 35 | 73 (8:1) |
14 | 1n | R 1 = 5-Br, R2 = H, R3 = p-MeC6H4, R4 = Ac | 2j | 35 | 56 (4:1) |
15 | 1o | R 1 = 5-Br, R2 = H, R3 = 3,4-DiMeC6H3, R4 = Ac | 2k | 36 | 55 (3:1) |
16 | 1p | R 1 = H, R2 = Me, R3 = C6H5, R4 = Ac | 2l | 36 | 60 (3:1) |
17 | 1q | R 1 = H, R2 = Me, R3 = p-MeC6H4, R4 = Ac | 2m | 37 | 50 (6:1) |
18 | 1r | R 1 = H, R2 = H, R3 = 2-thienyl, R4 = Ac | 2n | 36 | 63 (4:1) |
19 | 1s | — | 30 | _d | |
20 | 1t | R 1 = H, R2 = H, R3 = p-MeOC6H4, R4 = Ac | 20 | 24 | 60 |
Surprisingly, a completely different transformation occurred in the case of propargylic ester 1t bearing a strong electron-donating 4–OMeC6H5 group in R3 and a α,β-unsaturated ketone 2o was formed (entry 20, Scheme 3), suggesting that in this case the rate of hydration of allene intermediate is faster than that of the 1,5-hydride shift. On the basis of these facts, it is confirmed that the presence of an electron-donating group in R3 is crucial to the success of the reaction.10
To explore the mechanism of these cycloisomerizations, a deuterium-labeling experiment was performed as shown in Scheme 4. Propargylic acetate D-1a containing CD2 produced cycloadduct D-2a in 50% yield. A mixture was isolated and the structures were assigned by 1H NMR analysis (see supporting information†). Analysis by 1H NMR indicated about 7 to 3 ratio of products with the compound D-2a-1 being major, in line with the previously reported deuterium isotope effect, indicating a faster rate of hydride than deuteride in the 1,5-H−/D− shift reaction.11 The deuterium atom in D-1a at the α-position of the nitrogen was transferred to the benzylic position of the D-2a, thus supporting a hydride transfer mechanism.
Scheme 4 Deuterium-labeling experiment. |
2a was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.98–8.00 (m, 2 H), 7.59 (t, J = 7.2 Hz, 1 H), 7.46–7.49 (m, 2 H), 7.12 (t, J = 7.6 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.65 (t, J = 7.2 Hz, 1 H), 3.99–4.02 (m, 1 H), 3.71–3.78 (m, 1 H), 3.35–3.40 (m, 1 H), 2.96–3.03 (m, 1 H), 2.80–2.86 (m, 2 H), 1.71–1.77 (m, 3 H), 1.36–1.65 (m, 3 H); 13C NMR (100 MHz, CDCl3): δ 202.2, 146.1, 136.9, 133.3, 128.7, 128.6, 128.5, 128.3, 127.5, 123.1, 117.2, 112.9, 58.9, 48.5, 46.9, 32.4, 31.6, 25.4, 24.3; IR (neat, cm−1) 3399, 2920, 2852, 1677, 1585, 1450, 1057, 754, 705, 590; HRMS (ESI) m/z: calcd for C20H21NO: M + H = 292.1696; found: 292.1694. minor diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.93 (d, J = 7.2 Hz, 2 H), 7.52–7.56 (m, 1 H), 7.43 (t, J = 8.0 Hz, 2 H), 7.06–7.12 (m, 2 H), 6.65 (t, J = 7.2 Hz, 1 H), 6.49 (d, J = 7.6 Hz, 1 H), 3.84–3.89 (m, 1 H), 3.63–3.66 (m, 1 H), 3.38 (dd, J = 9.6, 8.0 Hz, 1 H), 3.27–3.32 (m, 1 H), 3.03 (dd, J = 11.6, 6.0 Hz, 1 H), 2.56–2.63 (m, 1 H), 1.84–1.86 (m, 1 H), 1.66–1.72 (m, 2 H), 1.34–1.59 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 199.2, 151.5, 137.0, 133.1, 133.0, 128.5, 128.0, 127.7, 124.5, 118.1, 106.6, 67.5, 45.8, 39.1, 38.5, 26.3, 24.5, 24.4;
2b was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.90 (d, J = 8.0 Hz, 2 H), 7.25–7.29 (m, 2 H), 7.12 (t, J = 7.6 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.65 (t, J = 7.6 Hz, 1 H), 3.99–4.02 (m, 1 H), 3.69–3.75 (m, 1 H), 3.32–3.38 (m, 1 H), 2.96–3.02 (m, 1 H), 2.78–2.86 (m, 2 H), 2.42 (s, 3 H), 1.71–1.77 (m, 3 H), 1.56–1.62 (m, 1 H), 1.26–1.47 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 201.8, 146.1, 144.2, 134.6, 129.5, 128.7, 128.5, 127.5, 123.2, 117.2, 112.9, 58.9, 48.5, 46.9, 32.6, 31.6, 25.5, 24.3, 21.6; IR (neat, cm−1) 3434, 2925, 2852, 1673, 1604, 1494, 1451, 1377, 1255, 1225, 1177, 1113, 1061, 747, 574; HRMS (ESI) m/z: calcd for C21H23NO: M + H = 306.1852; found: 306.1848.
2c was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.78–7.80 (m, 2 H), 7.34–7.41 (m, 2 H), 7.12 (t, J = 7.6 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.65 (t, J = 7.2 Hz, 1 H), 3.99–4.02 (m, 1 H), 3.71–3.77 (m, 1 H), 3.33–3.39 (m, 1 H), 2.95–3.02 (m, 1 H), 2.79–2.86 (m, 2 H), 2.41 (s, 3 H), 1.71–1.77 (m, 3 H), 1.55–1.65 (m, 1 H), 1.23–1.49 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 202.5, 146.1, 138.6, 137.1, 134.1, 128.9, 128.7, 128.6, 127.5, 125.6, 123.2, 117.2, 112.9, 58.9, 48.5, 47.1, 32.6, 31.6, 25.5, 24.3, 21.3; IR (neat, cm−1) 3336, 2929, 2851, 1675, 1601, 1494, 1451, 1370, 1253, 1161, 1050, 744, 550; HRMS (ESI) m/z: calcd for C21H23NO: M + H = 306.1852; found: 306.1850.
2d was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.73–7.77 (m, 2 H), 7.14–7.26 (m, 1 H), 7.10–7.14 (m, 1 H), 6.94 (d, J = 7.6 Hz, 1 H), 6.87 (d, J = 8.4 Hz, 1 H), 6.63–6.67 (m, 1 H), 3.99–4.03 (m, 1 H), 3.69–3.76 (m, 1 H), 3.32–3.37 (m, 1 H), 2.96–3.02 (m, 1 H), 2.77–2.86 (m, 2 H), 2.33 (s, 3 H), 2.32 (s, 3 H), 1.71–1.77 (m, 3 H), 1.56–1.62 (m, 1 H), 1.24–1.47 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 202.1, 146.1, 143.0, 137.2, 135.0, 130.0, 129.5, 128.8, 127.4, 126.1, 123.3, 117.1, 112.9, 59.0, 48.5, 46.8, 32.6, 31.6, 25.6, 24.3, 20.0, 19.8; IR (neat, cm−1) 3400, 2923, 2851, 1671, 1602, 1494, 1451, 1378, 1253, 1115, 1054, 793, 749, 708; HRMS (ESI) m/z: calcd for C22H25NO: M + H = 320.2009; found: 320.2006.
2e was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.91–7.94 (m, 2 H), 7.44–7.46 (m, 2 H), 7.12 (t, J = 7.6 Hz, 1 H), 6.93 (d, J = 7.6 Hz, 1 H), 6.85 (d, J = 8.4 Hz, 1 H), 6.66 (t, J = 7.2 Hz, 1 H), 3.98–4.01 (m, 1 H), 3.65–3.71 (m, 1 H), 3.32–3.38 (m, 1 H), 2.95–3.01 (m, 1 H), 2.78–2.86 (m, 2 H), 1.55–1.76 (m, 4 H), 1.38–1.49 (m, 1 H), 1.19–1.29 (m, 1 H); 13C NMR (100 MHz, CDCl3): δ 200.9, 146.0, 139.9, 135.3, 129.7, 129.1, 128.7, 127.6, 122.9, 117.3, 112.9, 58.8, 48.5, 47.1, 32.3, 31.6, 25.4, 24.3; IR (neat, cm−1) 3436, 2929, 2851, 1677, 1590, 1493, 1451, 1253, 1092, 1008, 839, 747, 534; HRMS (ESI) m/z: calcd for C20H20ClNO: M + H = 326.1306; found: 326.1301.
2f was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.84 (d, J = 8.4 Hz, 2 H), 7.62 (d, J = 8.4 Hz, 2 H), 7.12 (t, J = 7.6 Hz, 1 H), 6.93 (d, J = 7.6 Hz, 1 H), 6.85 (d, J = 8.4 Hz, 1 H), 6.65 (t, J = 7.2 Hz, 1 H), 3.98–4.01 (m. 1 H), 3.64–3.69 (m, 1 H), 3.33–3.38 (m, 1 H), 2.95–3.01 (m, 1 H), 2.78–2.86 (m, 2 H), 1.56–1.76 (m, 4 H), 1.20–1.49 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 201.1, 146.0, 135.7, 132.1, 129.8, 128.7, 128.6, 127.6, 122.9, 117.3, 112.9, 58.8, 48.5, 47.1, 32.3, 31.6, 25.4, 24.3; IR (neat, cm−1) 3403, 2923, 2853, 1764, 1681, 1452, 1381, 1243, 1061, 913, 746; HRMS (ESI) m/z: calcd for C20H20NOBr: M + H = 370.0801; found: 370.0806.
2g was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 8.05 (m, 4 H), 7.13 (t, J = 7.6 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.66 (t, J = 7.2 Hz, 1 H), 3.99–4.02 (m, 1 H), 3.72–3.78 (m, 1 H), 3.35–3.41 (m, 1 H), 2.96–3.03 (m, 1 H), 2.80–2.86 (m, 2 H), 2.65 (s, 3 H), 1.73–1.79 (m, 3 H), 1.28–1.69 (m, 3 H); 13C NMR (100 MHz, CDCl3): δ 201.7, 197.4, 146.0, 140.2, 140.1, 128.7, 128.6, 128.5, 127.6, 122.8, 117.3, 113.0, 58.8, 48.5, 47.6, 32.2, 31.6, 26.9, 25.3, 24.3; IR (neat, cm−1) 2927, 2852, 1683, 1601, 1495, 1259, 910, 748; HRMS (ESI) m/z: calcd for C22H23NO2: M + H = 334.1802; found: 334.1812.
2h was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.96–7.98 (m, 2 H), 7.59 (t, J = 7.2 Hz, 1 H), 7.47–7.50 (m, 2 H), 7.17–7.19 (m, 1 H), 7.03 (d, J = 2.0 Hz, 1 H), 6.69 (d, J = 8.8 Hz, 1H); 3.89–3.93 (m, 1 H), 3.67–3.72 (m, 1 H), 3.34–3.39 (m, 1 H), 2.91–2.97 (m, 1 H), 2.76–2.86 (m, 2 H), 1.70–1.79 (m, 3 H), 1.54–1.63 (m, 1 H), 1.39–1.49 (m, 1 H), 1.20–1.30 (m, 1 H); 13C NMR (100 MHz, CDCl3): δ 201.6, 145.1, 136.8, 133.4, 130.9, 130.1, 128.8, 128.3, 125.3, 114.5, 108.8, 58.7, 48.4, 46.8, 31.8, 31.5, 25.2, 24.2; IR (neat, cm−1) 3436, 2927, 2851, 1676, 1592, 1489, 1445, 1370, 1254, 1219, 793, 705, 546; HRMS (ESI) m/z: calcd for C20H20NOBr: M + H = 370.0801; found: 370.0795.
2i was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.83 (d, J = 8.4 Hz, 2 H), 7.63 (d, J = 8.8 Hz, 2 H), 7.17–7.19 (m, 1 H), 7.03 (d, J = 2.0 Hz, 1 H), 6.69 (d, J = 8.8 Hz, 1 H), 3.89–3.93 (m, 1 H), 3.60–3.66 (m, 1 H), 3.31–3.36 (m, 1 H), 2.90–2.97 (m, 1 H), 2.74–2.85 (m, 2 H), 1.66–1.79 (m, 3 H), 1.28–1.63 (m, 3 H); 13C NMR (100 MHz, CDCl3): δ 200.6, 145.0, 135.4, 132.2, 130.9, 130.1, 129.8, 128.8, 125.0, 114.5, 108.9, 58.7, 48.4, 46.8, 31.7, 31.5, 25.1, 24.2; IR (neat, cm−1) 3433, 2923, 2851, 1764, 1676, 1584, 1488, 1387, 1251, 1066, 1009, 746; HRMS (ESI) m/z: calcd for C20H19NOBr2: M + H = 447.9906; found: 447.9914.
2j was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.88 (d, J = 8.4 Hz, 2 H), 7.29 (d, J = 8.0 Hz, 2 H), 7.18 (dd, J = 6.8, 2.0 Hz, 1 H), 7.03 (d, J = 2.0 Hz, 1 H), 6.70 (d, J = 8.8 Hz, 1 H), 3.90–3.93 (m, 1 H), 3.64–3.70 (m, 1 H), 3.32–3.38 (m, 1 H), 2.91–2.98 (m, 1 H), 2.74–2.86 (m, 2 H), 2.43 (s, 3 H), 1.69–1.79 (m, 3 H), 1.26–1.59 (m, 3 H); 13C NMR (100 MHz, CDCl3): δ 201.2, 145.2, 144.4, 134.4, 130.9, 130.1, 129.5, 128.5, 125.4, 114.5, 108.8, 58.8, 48.5, 46.7, 31.9, 31.5, 25.2, 24.2, 21.6; IR (neat, cm−1) 3400, 2922, 2852, 2332, 1764, 1674, 1489, 1380, 1248, 1058, 913, 771, 747, 669; HRMS (ESI) m/z: calcd for C21H22NOBr: M + H = 384.0958; found: 384.0962.
2k was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.67–7.76 (m, 2 H), 7.10–7.25 (m, 3 H), 6.28–6.34 (m, 1 H), 3.81–3.87 (m, 1 H), 3.59–3.56 (m, 1 H), 3.23–3.37 (m, 2 H), 2.95–3.01 (m, 1 H), 2.57–2.64 (m, 1 H), 2.32 (s, 3 H), 2.31 (s, 3 H), 1.83–1.85 (m, 1 H), 1.31–1.69 (m, 5 H); 13C NMR (100 MHz, CDCl3): δ 198.5, 150.5, 142.7, 136.9, 135.6, 134.7, 130.2, 129.9, 129.8, 129.2, 127.5, 127.1, 125.8, 125.7, 109.5, 107.8, 67.5, 45.7, 38.9, 38.1, 26.0, 24.2, 24.1, 20.0, 19.8; IR (neat, cm−1) 2930, 2852, 1679, 1602, 1477, 1448, 1382, 1249, 1122, 803; HRMS (ESI) m/z: calcd for C22H24BrNO: M + H = 398.1114; found: 398.1111.
2l was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.99–8.01 (m, 2 H), 7.59 (t, J = 7.6 Hz, 1 H), 7.49 (t, J = 7.6 Hz, 2 H), 7.12 (t, J = 7.8 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H),6.65 (t, J = 7.2 Hz, 1 H), 3.99–4.04 (m, 1 H), 3.70–3.76 (m, 1 H), 3.38–3.43 (m, 1 H), 2.94–3.00 (m, 1 H), 2.81–2.88 (m, 2 H), 1.70–1.76 (m, 2 H), 1.21–1.64 (m, 3 H), 0.87 (d, J = 6.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3): δ 202.2, 145.9, 136.9, 133.3, 128.8, 128.6, 128.4, 127.5, 123.1, 117.2, 112.9, 58.3, 48.0, 47.1, 39.9, 33.8, 32.6, 30.9, 21.9; IR (neat, cm−1) 3440, 2923, 2849, 1677, 1600, 1495, 1452, 1373, 1239, 1210, 750, 702, 665; HRMS (ESI) m/z: calcd for C21H23NO: M + H = 306.1852; found: 306.1855.
2m was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.89–7.92 (m, 2 H), 7.25–7.30 (m, 2 H), 7.12 (t, J = 7.8 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.65 (t, J = 7.2 Hz, 1 H), 3.99–4.04 (m, 1 H), 3.68–3.74 (m, 1 H), 3.36–3.41 (m, 1 H), 2.94–3.01 (m, 1 H), 2.79–2.88 (m, 2 H), 2.43 (s, 3 H), 1.69–1.77 (m, 2 H), 1.53–1.63 (m, 2 H), 1.24–1.28 (m, 1 H), 0.87 (d, J = 6.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3): δ 201.8, 145.9, 144.3, 134.5, 129.5, 128.7, 128.5, 127.5, 123.2, 117.2, 112.9, 58.4, 48.1, 46.9, 39.9, 33.9, 32.7, 30.9, 21.9, 21.6; IR (neat, cm−1) 3399, 2019, 2850, 1672, 1603, 1494, 1453, 1374, 1241, 1045, 748, 610; HRMS (ESI) m/z: calcd for C22H25NO: M + H = 320.2009; found: 320.2001.
2n was obtained according to the above method as an oil. major diastereomer: 1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 3.6 Hz, 1 H), 7.68 (d, J = 4.8 Hz, 1 H), 7.10–7.17 (m, 2 H), 6.96 (d, J = 7.2 Hz, 1 H), 6.87 (d, J = 8.4 Hz, 1 H), 6.67 (t, J = 7.2 Hz, 1 H), 3.99–4.02 (m, 1 H), 3.50–3.56 (m, 1 H), 3.28–3.34 (m, 1 H) 3.05–3.12 (m, 1 H), 2.78–2.87 (m, 2 H), 1.76–1.78 (m, 3 H), 1.57–1.66 (m, 1 H), 1.28–1.47 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 194.9, 146.1, 144.9, 134.5, 132.2, 128.6, 128.4, 127.5, 123.0, 117.3, 113.1, 58.8, 49.1, 48.5, 32.6, 31.6, 25.5, 24.1; IR (neat, cm−1) 3399, 2925, 2851, 1653, 1494, 1413, 1253, 1057, 789, 744, 661; HRMS (ESI) m/z: calcd for C18H19NOS: M + H = 298.1260; found: 298.1254.
2o 1H NMR (400 MHz, CDCl3): δ 8.17 (d, J = 15.6 Hz, 1 H), 8.05 (d, J = 8.8 Hz, 2 H), 7.66 (d, J = 8.4 Hz, 1 H), 7.52 (d, J = 16.0 Hz, 1 H), 7.32–7.37 (m, 1 H), 7.05 (d, J = 7.6 Hz, 2 H), 6.98 (d, J = 8.8 Hz, 2 H), 3.89 (s, 3 H), 2.91–2.94 (m, 4 H), 1.73–1.78 (m, 4 H), 1.57–1.60 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ 189.4, 163.2, 154.4, 142.0, 131.4, 130.9, 130.8, 130.7, 129.2, 127.9, 122.3, 121.4, 119.0, 113.7, 113.6, 55.4, 54.4, 26.4, 24.2; IR (neat, cm−1): 2928, 1655, 1599, 1449, 1380, 1332, 1257, 1219, 1167, 1021, 835, 757, 575; HRMS (ESI) m/z: calcd for C21H23NO2: M + H = 322.1802; found: 322.1808.
D–2a1H NMR (400 MHz, CDCl3): δ 7.99 (d, J = 7.2 Hz, 2 H), 7.59 (t, J = 7.6 Hz, 1 H), 7.49 (t, J = 8.0 Hz, 2 H), 7.13 (t, J = 7.6 Hz, 1 H), 6.94 (d, J = 7.2 Hz, 1 H), 6.86 (d, J = 8.0 Hz, 1 H), 6.65 (t, J = 7.2 Hz, 1 H), 3.99–4.02 (m, 0.3 H), 3.71–3.78 (m, 1 H), 3.35–3.40 (m, 0.7 H), 2.96–3.03 (m, 1 H), 2.80–2.88 (m, 1.2 H), 1.38–1.79 (m, 6 H); 13C NMR (100 MHz, CDCl3): δ 202.2, 146.1, 137.1, 133.3, 128.8, 128.7, 128.4, 127.5, 123.1, 117.2, 112.9, 58.9, 47.1, 32.5, 31.6, 25.3, 24.3; HRMS (ESI) m/z: calcd for C20H19NOD2: M + H = 294.1821; found: 294.1825.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c1ra00789k |
This journal is © The Royal Society of Chemistry 2012 |